Clinical Research Directory

Inclusion Criteria: * Child 1 month to \< 18 years * Child newly diagnosed, i.e., within 16 weeks (112 days) from time of diagnosis of cancer not including the day of diagnosis, OR * Child with relapsed cancer, defined as within 16 weeks (112 days) of first-time relapse/evidence of progression of disease as noted by scan or biopsy after previous diagnosis of cancer. * Child provide assent if age ≥ 7 years * Poor prognosis, i.e., approximate \< 25 % estimated overall survival or at the discretion of the attending AND/OR: * Falls into one of the following diagnosis categories, including but not limited to: * Atypical teratoid rhabdoid tumor * Glioblastoma multiforme * Diffuse intrinsic brainstem glioma * Embryonal tumors with multilayered rosettes * Other high-grade glioma * Gliomatosis cerebri * Metastatic osteosarcoma * Metastatic Ewing sarcoma * Metastatic rhabdomyosarcoma * Metastatic desmoplastic small round cell tumor (DSRCT) * Other metastatic sarcoma/carcinoma-at discretion of attending * Metastatic unknown primary- or rare pathology- at discretion of attending * Parent(s) legal decision-maker(s) for child * Parent(s) ≥18 years of age * Parent (s) Informed of child's cancer diagnosis * Parent(s) Able to read, speak and understand English * Must be willing to be audio recorded during all study sessions. Exclusion Criteria: * The parent has neurological/cognitive impairments likely to interfere with study participation; * The child ≥ 7 years of age does not provide assent * Parent refuses to be audio recorded during sessions.